BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma L, Yang C, Zheng J, Chen Y, Xiao Y, Huang K. Non-polyphenolic natural inhibitors of amyloid aggregation. Eur J Med Chem 2020;192:112197. [PMID: 32172082 DOI: 10.1016/j.ejmech.2020.112197] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Pagano K, Tomaselli S, Molinari H, Ragona L. Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms. Front Neurosci 2020;14:619667. [PMID: 33414705 DOI: 10.3389/fnins.2020.619667] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
2 Terry C. Insights from nature: A review of natural compounds that target protein misfolding in vivo. Current Research in Biotechnology 2020;2:131-44. [DOI: 10.1016/j.crbiot.2020.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Piccialli I, Tedeschi V, Caputo L, D’errico S, Ciccone R, De Feo V, Secondo A, Pannaccione A. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes. Front Pharmacol 2022;13:876614. [DOI: 10.3389/fphar.2022.876614] [Reference Citation Analysis]
4 Gharibyan AL, Wasana Jayaweera S, Lehmann M, Anan I, Olofsson A. Endogenous Human Proteins Interfering with Amyloid Formation. Biomolecules 2022;12:446. [DOI: 10.3390/biom12030446] [Reference Citation Analysis]
5 Wang S, Zheng J, Ma L, Petersen RB, Xu L, Huang K. Inhibiting protein aggregation with nanomaterials: The underlying mechanisms and impact factors. Biochim Biophys Acta Gen Subj 2021;1866:130061. [PMID: 34822925 DOI: 10.1016/j.bbagen.2021.130061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sakalauskas A, Ziaunys M, Snieckute R, Smirnovas V. Autoxidation Enhances Anti-Amyloid Potential of Flavone Derivatives. Antioxidants (Basel) 2021;10:1428. [PMID: 34573060 DOI: 10.3390/antiox10091428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Agamennone M, Storchi L, Marrone A, Paciotti R. Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study. J Comput Aided Mol Des 2021;35:751-70. [PMID: 34110550 DOI: 10.1007/s10822-021-00393-7] [Reference Citation Analysis]
8 Kelley M, Sant'Anna R, Fernandes L, Palhano FL. Pentameric Thiophene as a Probe to Monitor EGCG's Remodeling Activity of Mature Amyloid Fibrils: Overcoming Signal Artifacts of Thioflavin T. ACS Omega 2021;6:8700-5. [PMID: 33817533 DOI: 10.1021/acsomega.1c00680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bisi N, Feni L, Peqini K, Pérez-Peña H, Ongeri S, Pieraccini S, Pellegrino S. α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques. Front Chem 2021;9:666585. [PMID: 34307295 DOI: 10.3389/fchem.2021.666585] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Saini RK, Goyal D, Goyal B. Targeting Human Islet Amyloid Polypeptide Aggregation and Toxicity in Type 2 Diabetes: An Overview of Peptide-Based Inhibitors. Chem Res Toxicol 2020;33:2719-38. [PMID: 33124419 DOI: 10.1021/acs.chemrestox.0c00416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Y, Yang C, Wang S, Yang D, Zhang Y, Xu L, Ma L, Zheng J, Petersen RB, Zheng L, Chen H, Huang K. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease. Int J Biol Macromol 2020;163:562-73. [PMID: 32629061 DOI: 10.1016/j.ijbiomac.2020.06.274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mavroidi B, Kaminari A, Matiadis D, Hadjipavlou-Litina D, Pelecanou M, Tzinia A, Sagnou M. The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer's Disease In Vitro. Brain Sci 2022;12:806. [PMID: 35741690 DOI: 10.3390/brainsci12060806] [Reference Citation Analysis]
13 Malafaia D, Albuquerque HMT, Silva AMS. Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review. Eur J Med Chem 2021;214:113209. [PMID: 33548635 DOI: 10.1016/j.ejmech.2021.113209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Stefanescu R, Stanciu GD, Luca A, Paduraru L, Tamba BI. Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer's Disease. Biomolecules 2020;10:E870. [PMID: 32517180 DOI: 10.3390/biom10060870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
15 Sevcuka A, White K, Terry C. Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus. Life 2022;12:583. [DOI: 10.3390/life12040583] [Reference Citation Analysis]
16 Takekiyo T, Yamada N, Amo T, Asano A, Yoshimura Y. Triiodide ion-induced inhibition of amyloid aggregate formation: A case study of α-synuclein. Journal of Molecular Liquids 2022;360:119446. [DOI: 10.1016/j.molliq.2022.119446] [Reference Citation Analysis]
17 Sahihi M, Gaci F, Navizet I. Identification of new alpha-synuclein fibrillogenesis inhibitor using in silico structure-based virtual screening. J Mol Graph Model 2021;108:108010. [PMID: 34425419 DOI: 10.1016/j.jmgm.2021.108010] [Reference Citation Analysis]
18 Ma L, Zheng J, Chen H, Zeng X, Wang S, Yang C, Li X, Xiao Y, Zheng L, Chen H, Huang K. A Systematic Screening of Traditional Chinese Medicine Identifies Two Novel Inhibitors Against the Cytotoxic Aggregation of Amyloid Beta. Front Pharmacol 2021;12:637766. [PMID: 33897425 DOI: 10.3389/fphar.2021.637766] [Reference Citation Analysis]
19 Takahashi D, Matsunaga E, Yamashita T, Caaveiro JM, Abe Y, Ueda T. Compound screening identified gossypetin and isoquercitrin as novel inhibitors for amyloid fibril formations of Vλ6 proteins associated with AL amyloidosis. Biochemical and Biophysical Research Communications 2022;596:22-8. [DOI: 10.1016/j.bbrc.2022.01.066] [Reference Citation Analysis]
20 Xie Y, Lu J, Yang T, Chen C, Bao Y, Jiang L, Wei H, Wu X, Zhao L, He S, Lin D, Liu F, Liu H, Yan X, Cui W. Phloroglucinol, a clinical-used antispasmodic, inhibits amyloid aggregation and degrades the pre-formed amyloid proteins. Int J Biol Macromol 2022:S0141-8130(22)01202-8. [PMID: 35667457 DOI: 10.1016/j.ijbiomac.2022.06.008] [Reference Citation Analysis]
21 Vittorio S, Adornato I, Gitto R, Peña-Díaz S, Ventura S, De Luca L. Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease. J Enzyme Inhib Med Chem 2020;35:1727-35. [PMID: 32924648 DOI: 10.1080/14756366.2020.1816999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Martínez-herrera M, Figueroa-gerstenmaier S, López-camacho PY, Millan-pacheco C, Balderas-altamirano MA, Mendoza-franco G, García-sierra F, Zavala-ocampo LM, Basurto-islas G. Multiadducts of C60 Modulate Amyloid-β Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and In Silico Studies. JAD 2022. [DOI: 10.3233/jad-215412] [Reference Citation Analysis]